BIOMAT Database Logo BIOMAT Database Logo

Neuromelanin magnetic resonance imaging of the substantia nigra in first episode psychosis patients consumers of illicit substances. 2018

Marta Tavares, and Sofia Reimão, and Inês Chendo, and Miguel Carvalho, and Pedro Levy, and Rita G Nunes
Instituto de Biofísica e Engenharia Biomédica, Faculdade de Ciências da Universidade de Lisboa, Campo Grande, 1749-016 Lisbon, Portugal; Faculdade de Ciências e Tecnologia, Universidade Nova de Lisboa, Campus da Caparica, 2829-516 Caparica, Portugal.

UI MeSH Term Description Entries
D008279 Magnetic Resonance Imaging Non-invasive method of demonstrating internal anatomy based on the principle that atomic nuclei in a strong magnetic field absorb pulses of radiofrequency energy and emit them as radiowaves which can be reconstructed into computerized images. The concept includes proton spin tomographic techniques. Chemical Shift Imaging,MR Tomography,MRI Scans,MRI, Functional,Magnetic Resonance Image,Magnetic Resonance Imaging, Functional,Magnetization Transfer Contrast Imaging,NMR Imaging,NMR Tomography,Tomography, NMR,Tomography, Proton Spin,fMRI,Functional Magnetic Resonance Imaging,Imaging, Chemical Shift,Proton Spin Tomography,Spin Echo Imaging,Steady-State Free Precession MRI,Tomography, MR,Zeugmatography,Chemical Shift Imagings,Echo Imaging, Spin,Echo Imagings, Spin,Functional MRI,Functional MRIs,Image, Magnetic Resonance,Imaging, Magnetic Resonance,Imaging, NMR,Imaging, Spin Echo,Imagings, Chemical Shift,Imagings, Spin Echo,MRI Scan,MRIs, Functional,Magnetic Resonance Images,Resonance Image, Magnetic,Scan, MRI,Scans, MRI,Shift Imaging, Chemical,Shift Imagings, Chemical,Spin Echo Imagings,Steady State Free Precession MRI
D008543 Melanins Insoluble polymers of TYROSINE derivatives found in and causing darkness in skin (SKIN PIGMENTATION), hair, and feathers providing protection against SUNBURN induced by SUNLIGHT. CAROTENES contribute yellow and red coloration. Allomelanins,Melanin,Phaeomelanins
D011618 Psychotic Disorders Disorders in which there is a loss of ego boundaries or a gross impairment in reality testing with delusions or prominent hallucinations. (From DSM-IV, 1994) Psychoses,Psychosis, Brief Reactive,Schizoaffective Disorder,Schizophreniform Disorders,Psychosis,Brief Reactive Psychoses,Brief Reactive Psychosis,Disorder, Psychotic,Disorder, Schizoaffective,Disorder, Schizophreniform,Disorders, Psychotic,Disorders, Schizoaffective,Disorders, Schizophreniform,Psychoses, Brief Reactive,Psychotic Disorder,Reactive Psychoses, Brief,Reactive Psychosis, Brief,Schizoaffective Disorders,Schizophreniform Disorder
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D013378 Substantia Nigra The black substance in the ventral midbrain or the nucleus of cells containing the black substance. These cells produce DOPAMINE, an important neurotransmitter in regulation of the sensorimotor system and mood. The dark colored MELANIN is a by-product of dopamine synthesis. Nigra, Substantia,Nigras, Substantia,Substantia Nigras
D017831 Diagnosis, Dual (Psychiatry) The co-existence of a substance abuse disorder with a psychiatric disorder. The diagnostic principle is based on the fact that it has been found often that chemically dependent patients also have psychiatric problems of various degrees of severity. Dual Diagnosis, Psychiatric,Dual Diagnosis,Psychiatric Diagnosis, Dual,Psychiatric Dual Diagnosis,Diagnoses, Dual,Diagnoses, Dual (Psychiatry),Diagnoses, Dual Psychiatric,Diagnoses, Psychiatric Dual,Diagnosis, Dual,Diagnosis, Dual Psychiatric,Diagnosis, Psychiatric Dual,Dual Diagnoses,Dual Diagnoses (Psychiatry),Dual Diagnoses, Psychiatric,Dual Diagnosis (Psychiatry),Dual Psychiatric Diagnoses,Dual Psychiatric Diagnosis,Psychiatric Diagnoses, Dual,Psychiatric Dual Diagnoses
D019966 Substance-Related Disorders Disorders related to substance use or abuse. Chemical Dependence,Drug Abuse,Drug Addiction,Drug Dependence,Drug Habituation,Drug Use Disorder,Drug Use Disorders,Organic Mental Disorders, Substance-Induced,Substance Abuse,Substance Dependence,Substance Related Disorder,Substance Use,Substance Use Disorder,Substance Use Disorders,Prescription Drug Abuse,Substance Addiction,Abuse, Drug,Abuse, Prescription Drug,Abuse, Substance,Addiction, Drug,Addiction, Substance,Chemical Dependences,Dependence, Chemical,Dependence, Drug,Dependence, Substance,Dependences, Chemical,Disorder, Drug Use,Disorder, Substance Related,Disorder, Substance Use,Disorders, Substance Related,Drug Abuse, Prescription,Habituation, Drug,Organic Mental Disorders, Substance Induced,Related Disorder, Substance,Related Disorders, Substance,Substance Abuses,Substance Uses,Use, Substance

Related Publications

Marta Tavares, and Sofia Reimão, and Inês Chendo, and Miguel Carvalho, and Pedro Levy, and Rita G Nunes
Neuromelanin Magnetic Resonance Imaging of the Substantia Nigra in Huntington's Disease.
January 2020, Journal of Huntington's disease,
Marta Tavares, and Sofia Reimão, and Inês Chendo, and Miguel Carvalho, and Pedro Levy, and Rita G Nunes
Substantia nigra neuromelanin magnetic resonance imaging in de novo Parkinson's disease patients.
March 2015, European journal of neurology,
Marta Tavares, and Sofia Reimão, and Inês Chendo, and Miguel Carvalho, and Pedro Levy, and Rita G Nunes
Substantia nigra neuromelanin magnetic resonance imaging in patients with different subtypes of Parkinson disease.
February 2021, Journal of neural transmission (Vienna, Austria : 1996),
Marta Tavares, and Sofia Reimão, and Inês Chendo, and Miguel Carvalho, and Pedro Levy, and Rita G Nunes
Neuromelanin magnetic resonance imaging of the substantia nigra in LRRK2-related Parkinson's disease.
September 2017, Movement disorders : official journal of the Movement Disorder Society,
Marta Tavares, and Sofia Reimão, and Inês Chendo, and Miguel Carvalho, and Pedro Levy, and Rita G Nunes
Standardized Data Acquisition for Neuromelanin-sensitive Magnetic Resonance Imaging of the Substantia Nigra.
September 2021, Journal of visualized experiments : JoVE,
Marta Tavares, and Sofia Reimão, and Inês Chendo, and Miguel Carvalho, and Pedro Levy, and Rita G Nunes
Neuromelanin magnetic resonance imaging of locus ceruleus and substantia nigra in Parkinson's disease.
July 2006, Neuroreport,
Marta Tavares, and Sofia Reimão, and Inês Chendo, and Miguel Carvalho, and Pedro Levy, and Rita G Nunes
Magnetic resonance imaging in first-episode psychosis.
October 2017, The British journal of psychiatry : the journal of mental science,
Marta Tavares, and Sofia Reimão, and Inês Chendo, and Miguel Carvalho, and Pedro Levy, and Rita G Nunes
Three-dimensional neuromelanin-sensitive magnetic resonance imaging of the substantia nigra in Parkinson's disease.
April 2018, European journal of neurology,
Marta Tavares, and Sofia Reimão, and Inês Chendo, and Miguel Carvalho, and Pedro Levy, and Rita G Nunes
Neuromelanin magnetic resonance imaging reveals increased dopaminergic neuron activity in the substantia nigra of patients with schizophrenia.
January 2014, PloS one,
Marta Tavares, and Sofia Reimão, and Inês Chendo, and Miguel Carvalho, and Pedro Levy, and Rita G Nunes
Magnetic resonance imaging of the thalamus in first-episode psychosis.
January 2001, The American journal of psychiatry,
Copied contents to your clipboard!